Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population
- Weitere Titel
-
Neue Biomarker der Herzinsuffizienz mit reduzierter und erhaltener Pumpfunktion in der generellen Bevölkerung
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hamburg, Universität Hamburg, Dissertation, 2020
- Schlagwort
-
Biochemical markers
Heart failure
Population
Kardiologie ; Herzinsuffizienz ; Biomarker
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
Staats- und Universitätsbibliothek Hamburg
- (wann)
-
2020
- Urheber
-
Lanfermann, Simon
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:gbv:18-104233
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lanfermann, Simon
- Zeller, Tanja
- Staats- und Universitätsbibliothek Hamburg
Entstanden
- 2020
Ähnliche Objekte (12)
P2Y12 inhibition in murine myocarditis results in reduced platelet infiltration and preserved ejection fraction
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
Right ventricular ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
P2Y12 inhibition in murine myocarditis results in reduced platelet infiltration and preserved ejection fraction
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
Right ventricular ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction
Sex and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Clinical Studies
P2Y12 inhibition in murine myocarditis results in reduced platelet infiltration and preserved ejection fraction
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Semaglutide in patients with obesity and heart failure across mildly reduced or preserved ejection fraction
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
Right ventricular ejection fraction
Coagulation disorders and thrombotic complications in heart failure with preserved ejection fraction
Current understanding of molecular pathophysiology of heart failure with preserved ejection fraction
Mechanistic differences in mouse models of heart failure with preserved ejection fraction
Heterogeneous Metabolic Response to Exercise Training in Heart Failure with Preserved Ejection Fraction